Meserine, a Novel Carbamate AChE Inhibitor, Ameliorates Scopolamine-Induced Dementia and Alleviates Amyloidogenesis of APP/PS1 Transgenic Mice

A review on cholinesterase inhibitors for Alzheimer’s disease

(2013) Preet Anand et al.   ARCHIVES OF PHARMACAL RESEARCH

Neurotrophic and Neuroprotective Actions of (−)- and (+)-Phenserine, Candidate Drugs for Alzheimer’s Disease

(2013) Anna M. Lilja et al.   PLoS One

Bis(9)-(−)-nor-meptazinol as a novel dual-binding AChEI potently ameliorates scopolamine-induced cognitive deficits in mice

(2012) Ting Liu et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Novel bis-(−)-nor-meptazinol derivatives act as dual binding site AChE inhibitors with metal-complexing property

(2012) Wei Zheng et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Systemic and Central Immunity in Alzheimer's Disease: Therapeutic Implications

(2011) Joseph Butchart et al.   CNS Neuroscience & Therapeutics

Multi-Target-Directed Ligands in Alzheimer's Disease Treatment

(2011) M. Bajda et al.   CURRENT MEDICINAL CHEMISTRY

Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease

(2011) Rafael León et al.   MEDICINAL RESEARCH REVIEWS

Alzheimer's Therapeutics: Translation of Preclinical Science to Clinical Drug Development

(2011) Alena V Savonenko et al.   NEUROPSYCHOPHARMACOLOGY

Alzheimer's Disease

(2011) D. J. Selkoe   Cold Spring Harbor Perspectives in Biology

MTDL Design Strategy in the Context of Alzheimers Disease: From Lipocrine to Memoquin and Beyond

(2009) M. Bolognesi et al.   CURRENT PHARMACEUTICAL DESIGN

Novel piperazine derivative PMS1339 exhibits tri-functional properties and cognitive improvement in mice

(2009) Jean Marc Miezan Ezoulin et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

The Crystal Structure of a Complex of Acetylcholinesterase with a Bis-(−)-nor-meptazinol Derivative Reveals Disruption of the Catalytic Triad

(2009) Aviv Paz et al.   JOURNAL OF MEDICINAL CHEMISTRY

Bis-(−)-nor-meptazinols as Novel Nanomolar Cholinesterase Inhibitors with High Inhibitory Potency on Amyloid-β Aggregation

(2008) Qiong Xie et al.   JOURNAL OF MEDICINAL CHEMISTRY

Multi-target-Directed Ligands To Combat Neurodegenerative Diseases

(2008) Andrea Cavalli et al.   JOURNAL OF MEDICINAL CHEMISTRY

Aged wild-type and APP, PS1, and APP+PS1 mice present similar deficits in associative learning and synaptic plasticity independent of amyloid load

(2008) A. Gruart et al.   NEUROBIOLOGY OF DISEASE

Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Aβ levels

(2008) Ana-María Simón et al.   NEUROBIOLOGY OF DISEASE

PMS777, a New Cholinesterase Inhibitor with Anti-Platelet Activated Factor Activity, Regulates Amyloid Precursor Protein Processing In Vitro

(2008) Hong-Qi Yang et al.   NEUROCHEMICAL RESEARCH